Candel Therapeutics Inc (CADL)

NASDAQ
5.68
-0.61(-9.70%)
  • Volume:
    88,083
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    5.65 - 6.75

CADL Overview

Prev. Close
6.29
Day's Range
5.65-6.75
Revenue
210K
Open
6.48
52 wk Range
5.51-14.78
EPS
-
Volume
88,083
Market Cap
162.96M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
44,770
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
28,689,842
Next Earnings Date
Mar 02, 2022
What is your sentiment on Candel Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Candel Therapeutics Inc Company Profile

Employees
41

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of cancer immunotherapy drugs. The company offers Gene Mediated Cytotoxic Immunotherapy technology-based drugs that are designed to work with radiation, chemotherapy, and surgery to eradicate residual tumor cells that could lead to recurrence or metastases. Its product candidates include CAN-2409, an off-the-shelf adenovirus product candidate, for the treatment of localized, primary prostate cancer and therapy for pancreatic cancer; and CAN-3110, its HSV product candidate, has been engineered for enhanced specificity and tumor cell killing, while minimizing toxicity on healthy tissue and indicated for the treatment of recurrent high-grade glioma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was founded in 1999 and is based in Needham, Massachusetts.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.